1315 Capital

1315 Capital

1315 Capital invests in medical technology, healthcare service, and specialty therapeutic companies.

1315 Capital is a private investment firm focused on providing expansion and growth capital to commercial-stage medical technology, healthcare service and specialty therapeutic companies. Founded in 2014 and headquartered in Philadelphia, they target $10-30 million investments with the potential to scale to $100 million revenue with the option for acquisition or public offering.

Investments

1315 Capital prefers to work in what they call an operating partner model of CEO and COO Executive, where 1315 works to leverage their operating teams experience to help build investment companies.

Their investments include Aktana, BioCoat, Inc., Centurion, CHC Solutions, Inc., Colorescience, Encore Dermatology, Genoptix, Greenbrook NeuroHealth Centers, Innovative Health, JDS Therapeutics, Onkos Surgical, Restorative Therapies and Solsys Medical.

Timeline

Funded Companies

Company
Website
Industry
Location
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
300,000,000
300,000,000
February 14, 2018
225,000,000
60,000,000
March 30, 2015
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.